Comprehensive, data-driven assessment
120+ targeted questions across 12 strategic dimensions ‐ backed by empirical benchmark research, fully scorecarded, and weighted with surgical precision.
120+ questions · 12 dimensionsSCALEUP.report is the data-driven assessment that shows investors and founders exactly what is blocking growth and where is the opportunity ‐ and how to fix it fast.
Built inside SCALEUP. LABS, using know-how from SCALEUP.house and forming as the spin-off, it combines two decades of scale-up experience serving to more than 1000+ growth clients. Now moving from person-led to AI & full automation driven discovery and reporting tool. Join the small minority of companies that break through their next ceiling.
Six things hold the assessment together. Remove any one of them and it turns back into a generic dashboard export.
120+ targeted questions across 12 strategic dimensions ‐ backed by empirical benchmark research, fully scorecarded, and weighted with surgical precision.
120+ questions · 12 dimensionsThe output is shaped by operators and investors who have run the playbooks themselves, so it reads like a judgment call, not an automated score.
Senior judgmentThe framework is refreshed with field learning, benchmark shifts, and operating patterns we see repeat across portfolios.
Living frameworkThe top 2–3 constraints surface fast, so teams move from diagnosis to action without a four-week wait for slides.
~240 min to prioritiesEvery finding points to a next-step playbook, which is what keeps the report usable after the first read-through.
1500+ templatesThe logic is built for multi-market use and holds across growth stages and sectors, not just one home market.
Cross-market logicA small senior core, extended by an agent layer that handles the volume work so the humans stay focused on the judgment calls.



The next major upgrade is planned to Q1 2027. There will more analytical tools, faster report creation, more efficient for both sides involved. Stay tuned!
Every engagement is interpreted by a top senior professional from the investment and startup world who can rapidly distinguish signal from noise and challenge management answers.
The platform roadmap accelerates evidence processing, adaptive questioning, benchmark matching, report production, and portfolio re-assessment-with senior oversight where judgment matters most.
No. It complements legal, financial, tax, cyber, and technical due diligence with a fast commercial, organisational, and leadership intelligence layer. It can also help determine where deeper confirmatory work is justified.
Angels, syndicates, VC and CVC teams, family offices, growth investors, private equity teams, search funds, strategic acquirers, boards, and founders who need a clear external view of a growth company.
Yes. It can independently validate priorities and current plans, expose scalability and evidence gaps, sharpen the investment narrative, improve the data room, and create a focused 90-day readiness plan before investor outreach or due diligence. Eventually it cross-check your plans and improve them by the external expert.
It can be useful when the scope, evidence sources, limitations, and commissioning context are transparent. The assessment should not be presented as investor endorsement or as a substitute for an investor’s own diligence. Independence and evidence discipline remain essential.
Yes. The same evidence base can become a Day‑0 operating baseline, a board agenda, a prioritised 90-day value-creation plan, and a reference point for repeated portfolio assessment.
In the highest report level, it helps founders and CEOs understand how their leadership profile, decision-making style, strengths, and potential blind spots relate to the specific gaps and opportunities identified in the business. The aim is to show where the leader is naturally well equipped to drive change, where complementary capabilities or clearer ownership may be needed, and how the leadership team can respond more effectively to the company’s next stage of growth. The process uses informed consent, validated instruments, qualified interpretation, and an agreed protocol for sensitive information. It is not a clinical diagnosis, an opaque founder score, or a standalone investment verdict.
Start with the sample report to see the structure, then request the assessment for your own business.